Skip to main content
logo
Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
6.29
-0.07 (-1.10%)
Sep 22, 2026, 11:55 AM EDT - Market open

Aura Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
652346411436389496
Market Cap Growth
72.71%-15.71%-5.92%12.22%-21.59%-
Enterprise Value
345202255308298631
Last Close Price
6.365.458.228.8610.5016.98

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
2.092.532.701.931.993.26
P/TBV Ratio
2.092.532.701.931.993.26

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.050.130.120.090.110.01
Net Debt / Equity Ratio
-0.97-0.93-0.87-0.91-0.86-0.97
Net Debt / EBITDA Ratio
2.241.141.392.472.844.30
Net Debt / FCF Ratio
2.971.491.633.203.024.29
Quick Ratio
16.657.8510.1318.3018.0620.27
Current Ratio
16.828.1510.7718.7618.8120.90
Return on Equity (ROE)
-53.49%-73.52%-46.01%-36.26%-33.78%-41.07%
Return on Assets (ROA)
-31.24%-40.06%-27.46%-22.18%-19.63%-24.19%
Return on Capital Employed (ROCE)
-42.00%-74.70%-57.40%-35.00%-28.20%-23.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-19.93%-30.68%-21.17%-17.51%-15.11%-7.11%
FCF Yield
-15.72%-24.61%-19.74%-14.79%-14.32%-6.96%
Buyback Yield / Dilution
-42.27%-21.52%-25.32%-32.34%-480.18%-1305.21%
SEC Filings: 10-K · 10-Q